| Schedule of Operating and Reportable Segments |
The tables below summarize information about our reportable segments. | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | | Total segment revenues* | $ | 226,206 | | | $ | 39,504 | | | | | $ | 265,710 | | | Cost of sales | 110,265 | | | 19,257 | | | | | 129,522 | | | Gross profit | 115,941 | | | 20,247 | | | | | 136,188 | | | Advertising and marketing | 28,930 | | | 5,738 | | | | | 34,668 | | | Contribution margin | $ | 87,011 | | | $ | 14,509 | | | | | $ | 101,520 | | | Other operating expenses | | | | | | | 49,000 | | | Operating income | | | | | | | $ | 52,520 | | * Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | | Total segment revenues* | $ | 212,578 | | | $ | 36,952 | | | | | $ | 249,530 | | | Cost of sales | 92,178 | | | 17,021 | | | | | 109,199 | | | Gross profit | 120,400 | | | 19,931 | | | | | 140,331 | | | Advertising and marketing | 28,954 | | | 5,983 | | | | | 34,937 | | | Contribution margin | $ | 91,446 | | | $ | 13,948 | | | | | $ | 105,394 | | | Other operating expenses | | | | | | | 33,638 | | | Operating income | | | | | | | $ | 71,756 | | * Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Revenues from Similar Product Groups |
The tables below summarize information about our segment revenues from similar product groups.
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | | Cough, Cold & Allergy | $ | 15,628 | | | $ | 5,677 | | | | | $ | 21,305 | | | Dermatologicals | 30,615 | | | 2,580 | | | | | 33,195 | | | Eye & Ear Care | 28,339 | | | 4,639 | | | | | 32,978 | | | Gastrointestinal | 47,141 | | | 15,061 | | | | | 62,202 | | | Oral Care | 18,458 | | | 3,900 | | | | | 22,358 | | | Pain Relief | 26,225 | | | 577 | | | | | 26,802 | | | Wellness, Sleep & Other | 12,559 | | | 1,768 | | | | | 14,327 | | | Women's Health | 47,241 | | | 5,302 | | | | | 52,543 | | | | | | | | | | | Total segment revenues | $ | 226,206 | | | $ | 39,504 | | | | | $ | 265,710 | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | | Cough, Cold & Allergy | $ | 13,353 | | | $ | 5,654 | | | | | $ | 19,007 | | | Dermatologicals | 27,852 | | | 2,257 | | | | | 30,109 | | | Eye & Ear Care | 27,781 | | | 4,527 | | | | | 32,308 | | | Gastrointestinal | 43,696 | | | 14,088 | | | | | 57,784 | | | Oral Care | 18,154 | | | 3,548 | | | | | 21,702 | | | Pain Relief | 27,258 | | | 1,674 | | | | | 28,932 | | | Wellness, Sleep & Other | 4,726 | | | 382 | | | | | 5,108 | | | Women's Health | 49,758 | | | 4,822 | | | | | 54,580 | | | | | | | | | | | | | | | | | | | Total segment revenues | $ | 212,578 | | | $ | 36,952 | | | | | $ | 249,530 | |
|